NEWS COMMENTARY

Digital therapeutic outperforms standard physiotherapy in clinical trial for back pain treatment in 40-patient pilot study

Published:
May 9, 2019
Coverage:
Digital Transformation More...
Activities:
Claims
13261 thumb square
by Danielle Bradnan
Very important

The digital therapeutic, developed by Kaia Health, is an mHealth app that teaches patients specific physical therapy treatment exercises in order to treat pain. The app, which directly replaces an in-person physician, is part of a growing trend in the healthcare space where digital therapeutics are increasingly approved by regulatory bodies to replace traditional modes of care, such as a specialist (Pear Therapeutics' reSET) or a pharmaceutical agent (VRHealth's menopause treatment). While challenges remain in supporting consumer adoption, clients should expect this trend to continue and look to adopt digital therapeutic agents to complement their offerings as a way to engage in a healthcare space previously monopolized by pharma.

For the original news article, click here .


Further Reading

Replacement digital therapeutics offer more opportunities than augmentation therapeutics

Analyst Insight | May 10, 2019

Defining Digital Therapeutics "Digital therapeutics" is a term with many different definitions, making an understanding of the space challenging. At Lux, we are using the definition provided by the Digital Therapeutics Alliance: digital therapeutics are products that deliver therapeutic agents ... Not part of subscription

Proteus lends digital therapeutic applications to oncology

News Commentary | January 22, 2019

Proteus Digital Health has unveiled plans to partner with Fairview Health Services to utilize its smart pill technology in its oral oncology treatments. The oral treatments will be augmented with the smart pill technology to allow for monitoring of treatment adherence, giving physicians the ... Not part of subscription

First FDA-approved software-only therapeutic has first commercial launch

News Commentary | November 27, 2018

The first software‑only therapeutic to be approved by the U.S. FDA is now commercially available. The product, called reSET, is a digital cognitive behavioral therapy program for substance use disorder, accessed through an app and designed to accompany outpatient care delivered by a physician. The ... To read more, click here.